Sugio, S., Kashima, A., Mochizuki, S., Noda, M
Key Takeaways Most doctors advise against using GLP-1 medications while breastfeeding due to limited human safety data
The compound's effects on insulin sensitivity and glucose metabolism require regular laboratory assessment, but many providers offer inadequate monitoring protocols
Notably, a clinical study demonstrated that T2DM patients receiving insulin therapy experienced significantly higher rates of pancreatitis compared to those treated with GLP-1RAs, and notably, no pancreatitis cases have been reported in clinical trials of the novel GLP-1RA Cotadutide, indicating that a comprehensive risk assessment of GLP-1RAs for pancreatic cancer remains premature pending additional data on these novel medications [8]
"I think it just kind of gives that glow, it gives that you've been out in the sun, you've been enjoying the day, you've been living life, so I enjoy that part of it," the 21-year-old said
In these disorders, insulin resistance is generally a major component, and treatment of the insulin resistance improves clinical outcomes []